LIOF | Enterprise Europe Network
HomeAgenda

ExpertiseUpdated on 3 January 2026

AI Value Assessment, HTA & Reimbursement Strategy in Healthcare

Katarzyna Markiewicz-Barreaux

CEO and Co-Founder of Valiant Health at Valiant Health

Vessem, Netherlands

About

Valiant Health offers expertise at the intersection of healthcare AI, value assessment, HTA, reimbursement, and real-world adoption. We support AI developers, health systems, payers, and public stakeholders in moving beyond algorithmic performance toward credible, decision-grade evidence of clinical, economic, and organizational value.

Our expertise includes:

  • Structuring AI value assessment across the full lifecycle

  • Translating clinical and real-world evidence into HTA- and payer-relevant narratives

  • Understanding reimbursement pathways and adoption barriers across European health systems

  • Evaluating why AI solutions succeed or fail after regulatory approval

  • Supporting evidence strategies aligned with reimbursement and scaling, not just compliance

We are interested in connecting with organizations and professionals working on AI adoption, reimbursement, evaluation, policy, and implementation, as well as those seeking to validate, position, or scale AI solutions within real healthcare systems.

Organisation

Valiant Health

Software/App Producer (SME & Industry)

Vessem, Netherlands